Grace Therapeutics, Inc. Proceeds from Issuance of Private Placement
Grace Therapeutics, Inc. (GRCE) had Proceeds from Issuance of Private Placement of $13.71 million as of 2025-02-11, per its 10-K filed 2026-06-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-06-18
- 2025-02-11: Proceeds from Issuance of Private Placement $13.71M.
- 2023-09-24: Proceeds from Issuance of Private Placement $7.50M; Proceeds from Issuance of Private Placement as first filed $7.50K.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement as first filed |
|---|---|---|
| 2025-02-11 | $13.71M 10-K · filed 2026-06-18 | |
| 2023-09-24 | $7.50M 10-Q · filed 2024-11-13 | $7.50K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |